Xu W - Search Results

1

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L. Xia S, et al. Among authors: xu w. Cell Res. 2020 Apr;30(4):343-355. doi: 10.1038/s41422-020-0305-x. Epub 2020 Mar 30. Cell Res. 2020. PMID: 32231345 Free PMC article.

2

[Immunological reaction between the peptides from S1 domain of SARS coronavirus S-protein and the serum from SARS patients].

Zhang JJ, Wu SY, Xu W, Hou JL, Wang ZH, Jiang SB, Wu SG. Zhang JJ, et al. Among authors: xu w. Di Yi Jun Yi Da Xue Xue Bao. 2004 Jul;24(7):789-90, 797. Di Yi Jun Yi Da Xue Xue Bao. 2004. PMID: 15257904 Chinese.

3

[Inhibitory effect of polysaccharides on the six-alpha-helix bundle formation of HIV gp41 protein].

Wen XY, Wu SY, Xu W, Lv L, Liu SW, Rao JJ, Zhang JJ, Wang GF, Wan SH, Wu SG. Wen XY, et al. Among authors: xu w. Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1498-500. Nan Fang Yi Ke Da Xue Xue Bao. 2007. PMID: 17959523 Chinese.

4

[Isolation and characterization of the anti-HIV active component from Eucommia ulmoides].

Lv L, Sun YR, Xu W, Liu SW, Rao JJ, Wu SG. Lv L, et al. Among authors: xu w. Zhong Yao Cai. 2008 Jun;31(6):847-50. Zhong Yao Cai. 2008. PMID: 18998566 Chinese.

5

Crystal structure of group II chaperonin in the open state.

Huo Y, Hu Z, Zhang K, Wang L, Zhai Y, Zhou Q, Lander G, Zhu J, He Y, Pang X, Xu W, Bartlam M, Dong Z, Sun F. Huo Y, et al. Among authors: xu w. Structure. 2010 Oct 13;18(10):1270-9. doi: 10.1016/j.str.2010.07.009. Structure. 2010. PMID: 20947016 Free PMC article.

6

Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China.

Xu W, Lu L, Shen B, Li J, Xu J, Jiang S. Xu W, et al. Among authors: xu j. Clin Infect Dis. 2013 Sep;57(6):919-21. doi: 10.1093/cid/cit396. Epub 2013 Jun 11. Clin Infect Dis. 2013. PMID: 23759348 Free PMC article. No abstract available.

7

Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.

Lu L, Yu F, DU LY, Xu W, Jiang SB. Lu L, et al. Among authors: xu w. Chin Med J (Engl). 2013 Jun;126(12):2374-9. Chin Med J (Engl). 2013. PMID: 23786957 Review.

8

PA-356R is a unique signature of the avian influenza A (H7N9) viruses with bird-to-human transmissibility: potential implication for animal surveillances.

Xu W, Sun Z, Liu Q, Xu J, Jiang S, Lu L. Xu W, et al. Among authors: xu j. J Infect. 2013 Nov;67(5):490-4. doi: 10.1016/j.jinf.2013.08.001. Epub 2013 Aug 9. J Infect. 2013. PMID: 23933287 No abstract available.

9

Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs.

Xu W, Wang Q, Yu F, Lu L, Jiang S. Xu W, et al. J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):1-6. doi: 10.1097/QAI.0000000000000265. J Acquir Immune Defic Syndr. 2014. PMID: 24977378

10

Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection.

Sun Z, Wang Q, Jia R, Xia S, Li Y, Liu Q, Xu W, Xu J, Du L, Lu L, Jiang S. Sun Z, et al. Among authors: xu w, xu j. Viruses. 2015 Feb 16;7(2):798-819. doi: 10.3390/v7020798. Viruses. 2015. PMID: 25690799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,974 results

Search Page